OTCMKTS:BLGX - Biologix Hair Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.39 +0.12 (+44.44 %)
(As of 05/22/2019 01:01 PM ET)
Previous Close$0.2730
Today's Range$0.25 - $0.39
52-Week Range$0.01 - $0.30
Volume27,864 shs
Average Volume2,367 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Red Eye Guys Ltd., through its subsidiaries, develops and manufactures Biologix Hair Therapy System, a compound and delivery system to treat follicle nutrient deficiency syndrome (FNDS). Its Biologix Hair Therapy System includes Biologix Revive, a hair formula that is administered as a series of shallow injections using a needle targeting the follicles starved by FNDS. Its solution is used to treat reverse and avert FNDS, and alopecia areata. The company was formerly known as Biologix Hair, Inc. and changed its name to Red Eye Guys Ltd. in April 2014. The company is based in Toronto, Canada with subsidiaries in Barbados and Panama.

Receive BLGX News and Ratings via Email

Sign-up to receive the latest news and ratings for BLGX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Household & Personal Products
Sub-IndustryN/A
SectorConsumer Defensive
Current SymbolOTCMKTS:BLGX
CUSIP09072K109
Phone+1-647-3445900

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Biologix Hair (OTCMKTS:BLGX) Frequently Asked Questions

What is Biologix Hair's stock symbol?

Biologix Hair trades on the OTCMKTS under the ticker symbol "BLGX."

Has Biologix Hair been receiving favorable news coverage?

News coverage about BLGX stock has trended neutral recently, InfoTrie reports. InfoTrie identifies negative and positive media coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Biologix Hair earned a media sentiment score of 0.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Biologix Hair's key competitors?

Who are Biologix Hair's key executives?

Biologix Hair's management team includes the folowing people:
  • Mr. Ronald Holland, Director and Pres of Biologix Hair (Canada) Inc (Age 69)
  • Dr. Michael Stocker Ph.D., Chief Exec. Officer and Director (Age 51)
  • Mr. Peter Wiget, Chief Financial Officer (Age 55)
  • Mr. Todd A. Harrison, Chief Legal Counsel
  • Mr. Craig L. Ziering, Chairman of Medical Advisory Board and Pres of R&D

How do I buy shares of Biologix Hair?

Shares of BLGX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Biologix Hair's stock price today?

One share of BLGX stock can currently be purchased for approximately $0.39.

What is Biologix Hair's official website?

The official website for Biologix Hair is http://www.biologixhair.com/.

How can I contact Biologix Hair?

Biologix Hair's mailing address is 82 Avenue Rd, TORONTO, ON M5R 2H2, Canada. The company can be reached via phone at +1-647-3445900.


MarketBeat Community Rating for Biologix Hair (OTCMKTS BLGX)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  50 (Vote Outperform)
Underperform Votes:  43 (Vote Underperform)
Total Votes:  93
MarketBeat's community ratings are surveys of what our community members think about Biologix Hair and other stocks. Vote "Outperform" if you believe BLGX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BLGX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/22/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel